Dr. Richard L. Gallo, MD, PhD
Biography & Research Background
Richard L. Gallo, MD, PhD, is a Professor at the University of California, San Diego, Division of Dermatology. His research has been pivotal in defining LL-37's role in skin innate immunity and dermatological diseases. He demonstrated that LL-37 expression in the skin is induced by injury and is critical for defense against infections like Group A Streptococcus. His work linked abnormal LL-37 levels to psoriasis (overexpression) and atopic dermatitis (suppression), and established the regulation of LL-37 by Vitamin D. Key publications: 'Innate antimicrobial peptide protects the skin from invasive bacterial infection' (2001), 'Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization' (2007). Richard L. Gallo is referenced as a leading scientist in LL-37 research. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Richard L. Gallo, MD, PhD is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Richard L. Gallo, MD, PhD is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.